Molecular predictors of response to chemotherapy in lung cancer.
about
Increased mRNA expression levels of ERCC1, OGG1 and RAI in colorectal adenomas and carcinomas.Effects of base excision repair gene polymorphisms on pancreatic cancer survivalDistinguishing Lung Adenocarcinoma from Lung Squamous Cell Carcinoma by Two Hypomethylated and Three Hypermethylated Genes: A Meta-Analysis.Sarcomas and pharmacogenetics.Developing innovative strategies for advanced transitional cell carcinoma of the bladder.The future in diagnosis and staging of lung cancer. Molecular techniques.Predictive value of ERCC1 and XPD polymorphism in patients with advanced non-small cell lung cancer receiving platinum-based chemotherapy: a systematic review and meta-analysis.Higher Expression of ERCC1 May Be Associated with Resistance to Adjuvant Platinum-Based Chemotherapy in Gastric Cancer.Pharmacogenomic considerations in the treatment of muscle-invasive bladder cancer.Genetic polymorphisms of XPD and CDA and lung cancer riskHigh-level mRNA of excision repair cross-complementation group 1 gene is associated with poor outcome of platinum-based doublet chemotherapy of advanced nonsmall cell lung cancer patients.Drug resistance associates with activation of Nrf2 in MCF-7/DOX cells, and wogonin reverses it by down-regulating Nrf2-mediated cellular defense response.ERCC1 predicts outcome in patients with gastric cancer treated with adjuvant cisplatin-based chemotherapy.The effect of ERCC1 and ERCC2 gene polymorphysims on response to cisplatin based therapy in osteosarcoma patients.
P2860
Q33254229-2354F9E7-5E99-4F0B-8C98-B977C5D8E197Q35842670-6471572A-9E28-48B3-9BAF-2BC50EDE10A2Q35919451-269406C5-DADA-4108-9618-402BA6E3F687Q36249224-9EAF3DCA-4DB9-4CAC-AC05-E80A1E24FEB2Q36352085-0F5702F4-388C-4B12-A154-A80A22F6838CQ36606755-1637E70E-58C0-4D69-9E6D-F659FBD4A6C8Q37689573-39585495-FA90-4949-BF31-832A005ABE0FQ39012762-F3D968E1-D882-4950-BF7C-A33E82296491Q39459198-F55714A6-FFA1-441C-9079-6A2592079E3CQ41831329-DA511A1F-87D6-46A5-8227-61A0E02422D1Q43053810-54BAAA77-667E-4AF6-8635-24DAF39395D5Q45349809-C4C1021A-582C-4920-9F52-5D803A50A1B6Q46888766-A5990000-456B-42DA-B353-64690330A92FQ55455554-A199CEEC-A28D-46F1-9A81-35E41886D085
P2860
Molecular predictors of response to chemotherapy in lung cancer.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Molecular predictors of response to chemotherapy in lung cancer.
@ast
Molecular predictors of response to chemotherapy in lung cancer.
@en
type
label
Molecular predictors of response to chemotherapy in lung cancer.
@ast
Molecular predictors of response to chemotherapy in lung cancer.
@en
prefLabel
Molecular predictors of response to chemotherapy in lung cancer.
@ast
Molecular predictors of response to chemotherapy in lung cancer.
@en
P2093
P1433
P1476
Molecular predictors of response to chemotherapy in lung cancer.
@en
P2093
Agusti Barnadas
Aurelio Ariza
Jose Luis Mate
Miquel Taron
Mireia Margel
Noemí Reguart
Pedro Méndez
Rosario García-Campelo
P356
10.1053/J.SEMINONCOL.2003.12.011
P433
P577
2004-02-01T00:00:00Z